129 related articles for article (PubMed ID: 6794183)
21. Mutagenicity and toxicity of aflatoxin precursors.
Dunn JJ; Lee LS; Ciegler A
Environ Mutagen; 1982; 4(1):19-26. PubMed ID: 6802632
[TBL] [Abstract][Full Text] [Related]
22. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1.
Robertson IG; Zeiger E; Goldstein JA
Carcinogenesis; 1983; 4(1):93-6. PubMed ID: 6295661
[TBL] [Abstract][Full Text] [Related]
23. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
Swenson DH; Lin JK; Miller EC; Miller JA
Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
[TBL] [Abstract][Full Text] [Related]
24. The metabolism of aflatoxin B1 by hepatocytes isolated from rats following the in vivo administration of some xenobiotics.
Metcalfe SA; Neal GE
Carcinogenesis; 1983 Aug; 4(8):1007-12. PubMed ID: 6409441
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and degradation of aflatoxins by Aspergillus parasiticus. II. Comparative toxicity and mutagenicity of aflatoxin B1 and its autolytic breakdown products.
Huynh VL; Gerdes RG; Lloyd AB
Aust J Biol Sci; 1984; 37(3):123-9. PubMed ID: 6440522
[TBL] [Abstract][Full Text] [Related]
26. Preferential binding of aflatoxin B1 to the transcriptionally active regions of rat liver nucleolar chromatin in vivo and in vitro.
Yu FL
Carcinogenesis; 1983; 4(7):889-93. PubMed ID: 6409439
[TBL] [Abstract][Full Text] [Related]
27. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver.
Yoshizawa H; Uchimaru R; Kamataki T; Kato R; Ueno Y
Cancer Res; 1982 Mar; 42(3):1120-4. PubMed ID: 6800645
[TBL] [Abstract][Full Text] [Related]
28. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes.
Shimada T; Nakamura S; Imaoka S; Funae Y
Toxicol Appl Pharmacol; 1987 Oct; 91(1):13-21. PubMed ID: 3118508
[TBL] [Abstract][Full Text] [Related]
29. The effect of phenobarbital pretreatment on the metabolism, covalent binding, and cytotoxicity of aflatoxin B1 in primary cultures of rat hepatocytes.
Loury DJ; Hsieh DP; Byard JL
J Toxicol Environ Health; 1984; 13(1):145-59. PubMed ID: 6201621
[TBL] [Abstract][Full Text] [Related]
30. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
Uwaifo AO; Bababunmi EA
Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
[TBL] [Abstract][Full Text] [Related]
31. Effects of phenobarbital on the biliary excretion of aflatoxin P1-glucuronide and aflatoxin B1-S-glutathione in the rat.
Holeski CJ; Eaton DL; Monroe DH; Bellamy GM
Xenobiotica; 1987 Feb; 17(2):139-53. PubMed ID: 3105186
[TBL] [Abstract][Full Text] [Related]
32. Rat hepatoma cells show extreme sensitivity to aflatoxin B1.
Billings PC; Uwaifo AO; Heidelberger C
Toxicol Appl Pharmacol; 1982 Nov; 66(2):297-304. PubMed ID: 6819656
[No Abstract] [Full Text] [Related]
33. The activation of aflatoxin B1 in liver slices and in bacterial mutagenicity assays using livers from different species including man.
Booth SC; Bösenberg H; Garner RC; Hertzog PJ; Norpoth K
Carcinogenesis; 1981; 2(10):1063-8. PubMed ID: 6794925
[No Abstract] [Full Text] [Related]
34. Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b5 in the activation of aflatoxin B1.
Ueno Y; Ishii K; Omata Y; Kamataki T; Kato R
Carcinogenesis; 1983 Aug; 4(8):1071-3. PubMed ID: 6409444
[TBL] [Abstract][Full Text] [Related]
35. Detoxification of genotoxic compounds as a threshold mechanism limiting their carcinogenicity.
De Flora S
Toxicol Pathol; 1984; 12(4):337-43. PubMed ID: 6442795
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of neonatal phenobarbital exposure on aflatoxin b1 disposition in adult rats.
Faris RA; Campbell TC
Cancer Res; 1983 Jun; 43(6):2576-83. PubMed ID: 6406048
[No Abstract] [Full Text] [Related]
37. Purification and characterization of a form of cytochrome P-450 with high specificity for aflatoxin B1 from 3-methylcholanthrene-treated hamster liver.
Mizokami K; Nohmi T; Fukuhara M; Takanaka A; Omori Y
Biochem Biophys Res Commun; 1986 Sep; 139(2):466-72. PubMed ID: 3094515
[TBL] [Abstract][Full Text] [Related]
38. The effect of inducers of mixed-function oxidases on hepatic microsome-mediated aflatoxin B1 transformation in C3H/10T1/2 cells.
Faletto MB; Gurtoo HL
Toxicol Appl Pharmacol; 1989 Apr; 98(2):252-62. PubMed ID: 2496488
[TBL] [Abstract][Full Text] [Related]
39. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
Ishii K; Maeda K; Kamataki T; Kato R
Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
[TBL] [Abstract][Full Text] [Related]
40. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
